|
ABHD15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.117700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.864100E-02 |
| Normal-vs-Stage2 |
2.476400E-01 |
| Normal-vs-Stage3 |
7.386600E-01 |
| Normal-vs-Stage4 |
9.296200E-01 |
| Stage1-vs-Stage2 |
9.642400E-01 |
| Stage1-vs-Stage3 |
2.335600E-01 |
| Stage1-vs-Stage4 |
3.848000E-01 |
| Stage2-vs-Stage3 |
4.085000E-01 |
| Stage2-vs-Stage4 |
4.099200E-01 |
| Stage3-vs-Stage4 |
7.698000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.142700E-03 |
| Normal-vs-AfricanAmerican |
5.976800E-01 |
| Normal-vs-Asian |
5.177200E-01 |
| Caucasian-vs-AfricanAmerican |
3.678200E-02 |
| Caucasian-vs-Asian |
6.729800E-01 |
| AfricanAmerican-vs-Asian |
7.994000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.208150E-02 |
| Normal-vs-Female |
4.411500E-02 |
| Male-vs-Female |
9.456800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.601600E-01 |
| Normal-vs-Extreme_Weight |
1.861030E-01 |
| Normal-vs-Obese |
7.876500E-02 |
| Normal-vs-Extreme_Obese |
2.715600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.965800E-01 |
| Normal_Weight-vs-Obese |
2.745000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.216200E-01 |
| Extreme_Weight-vs-Obese |
6.358000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.473400E-01 |
| Obese-vs-Extreme_Obese |
5.996000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.980000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.619650E-03 |
| Normal-vs-Age(61-80Yrs) |
1.808760E-01 |
| Normal-vs-Age(81-100Yrs) |
9.155800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.937200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.718970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.378400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.997700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.447050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.935800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.737770E-03 |
| Normal-VS-Type2 PRCC |
1.382180E-01 |
| Normal-VS-KIRP CIMP |
2.354200E-01 |
| Normal-VS-Unclassified PRCC |
4.496000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.598800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.704200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.489400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.346600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.458600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.519400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.131000E-01 |
| Normal-vs-N1 |
3.449400E-01 |
| Normal-vs-N2 |
4.379600E-01 |
| N0-vs-N1 |
5.003800E-01 |
| N0-vs-N2 |
2.237200E-01 |
| N1-vs-N2 |
6.385000E-01 |
|
|
